HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc. cut its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 50.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 24,800 shares of the company's stock after selling 24,900 shares during the period. Adams Diversified Equity Fund Inc.'s holdings in HCA Healthcare were worth $8,570,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Farther Finance Advisors LLC increased its holdings in shares of HCA Healthcare by 26.9% in the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after purchasing an additional 242 shares during the period. Brighton Jones LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $1,021,000. OLD National Bancorp IN grew its holdings in HCA Healthcare by 5.2% during the first quarter. OLD National Bancorp IN now owns 1,049 shares of the company's stock worth $362,000 after acquiring an additional 52 shares during the period. Metropolis Capital Ltd purchased a new position in shares of HCA Healthcare during the 1st quarter valued at approximately $117,984,000. Finally, Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of HCA Healthcare by 117.5% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 92,495 shares of the company's stock valued at $27,762,000 after purchasing an additional 49,968 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of HCA opened at $379.06 on Wednesday. The firm's 50 day moving average price is $363.94 and its 200 day moving average price is $335.66. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a market cap of $91.19 billion, a P/E ratio of 16.85, a PEG ratio of 1.31 and a beta of 1.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the prior year, the business earned $5.36 EPS. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a $0.72 dividend. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. HCA Healthcare's payout ratio is currently 12.81%.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.30% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Barclays set a $416.00 price objective on HCA Healthcare and gave the company an "overweight" rating in a report on Monday, June 2nd. Finally, Guggenheim initiated coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Seven analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $394.33.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.